BioLine Rx(BLRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BLRX BioLine Rx

Pre-Mkt 04-14 04:43:54 EDT

2.75

+0.32

+13.17%

盘前2.95

+0.20+7.27%

04:14 EDT

High2.76	Low2.50	Vol24.56K
Open2.50	D1 Closing2.43	Amplitude10.70%
Mkt Cap10.23M	Tradable Cap9.74M	Total Shares3.72M
T/O64.96K	T/O Rate0.69%	Tradable Shares3.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"BLRX","market":"US","secType":"STK","nameCN":"BioLine Rx","latestPrice":2.75,"timestamp":1744401600000,"preClose":2.43,"halted":0,"volume":24555,"hourTrading":{"tag":"盘前","latestPrice":2.95,"preClose":2.75,"latestTime":"04:14 EDT","volume":614,"amount":1811.3000000000002,"timestamp":1744618481471},"delay":0,"floatShares":3543154,"shares":3721003,"eps":-4.6176,"marketStatus":"Pre-Mkt","change":0.32,"latestTime":"04-14 04:43:54 EDT","open":2.5,"high":2.76,"low":2.5,"amount":64956.785334,"amplitude":0.106996,"askPrice":2.96,"askSize":50,"bidPrice":2.69,"bidSize":257,"shortable":3,"etf":0,"ttmEps":-4.6176,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1744637400000},"marketStatusCode":1,"adr":0,"adrRate":600,"exchange":"NASDAQ","adjPreClose":2.75,"preHourTrading":{"tag":"盘前","latestPrice":2.95,"preClose":2.75,"latestTime":"04:14 EDT","volume":614,"amount":1811.3000000000002,"timestamp":1744618481471},"postHourTrading":{"tag":"盘后","latestPrice":2.75,"preClose":2.75,"latestTime":"16:53 EDT","volume":89,"amount":254.6618,"timestamp":1744404798656},"volumeRatio":0.6053814971410746,"impliedVol":0.2629,"impliedVolPercentile":0.0843},"requestUrl":"/m/hq/s/BLRX/wiki","defaultTab":"wiki","newsList":[{"id":"2524269017","title":"BLRX: 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2524269017","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524269017?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 18:12","pubTimestamp":1743675120,"startTime":"0","endTime":"0","summary":"BioLineRx Ltd.  reported full-year 2024 results, with revenues reaching $28.9 million. As the company completes its commercialization transition of Aphexda  to Gamida Cell, its focus is shifting to replenishing its pipeline with a new development asset. Management reiterated their objective of acquiring early-stage assets in oncology and rare diseases. The team is conducting due diligence with several parties and remains on track to make a decision in 2025. However, no material details on progress were disclosed.BioLineRx reported 2024 sales of $28.9 million producing a net loss of  million or  per share. Ignoring non-operating income, net loss was  million. The results were announced in a press release on March 31st, 2025 followed by a conference call with management and the filing of Form 20-F providing additional information.Research and development expenses totaled $9.1 million, down 27% from$12.5 million, on account of lower expenses related to payroll, services professional fees ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/blrx-2024-financial-results-101200694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BLRX","BK4139"],"gpt_icon":0},{"id":"2524351441","title":"BioLine Rx Ltd (BLRX) Q4 2024 Earnings Call Highlights: Strategic Licensing and Market ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2524351441","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524351441?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 05:00","pubTimestamp":1743627626,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.BioLine Rx Ltd  executed a significant licensing agreement with AirMed Limited, providing a $10 million upfront payment and potential commercial milestones of $87 million.The company received a $9 million equity investment from High Bridge Capital, strengthening its financial position.The licensing agreement allows BioLine Rx Ltd  to reduce its cash burn significantly, extending its cash runway into 2026.The company achieved a 10% market share milestone for its stem cell mobilization agent, Effexta, in the US market.The company faces uncertainties in the timing of revenue generation from its licensing agreements, particularly in the Asian market.GuruFocus has detected 3 Warning Signs with BLRX.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioline-rx-ltd-blrx-q4-210026262.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BLRX"],"gpt_icon":0},{"id":"2524697462","title":"BioLine RX Cut to Hold From Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2524697462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524697462?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 19:54","pubTimestamp":1743594840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2025 07:54 ET (11:54 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX","BK4139"],"gpt_icon":0},{"id":"2524121924","title":"BioLineRx downgraded to Hold from Buy at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2524121924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524121924?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 04:36","pubTimestamp":1743539771,"startTime":"0","endTime":"0","summary":"JonesResearch analyst Justin Walsh downgraded BioLineRx (BLRX) to Hold from Buy without a price target following the Q4 report. BioLineRx is on “so...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biolinerx-downgraded-to-hold-from-buy-at-jonesresearch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biolinerx-downgraded-to-hold-from-buy-at-jonesresearch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLRX","BK4139"],"gpt_icon":0},{"id":"2524121960","title":"JonesTrading downgrades Bioline RX Ltd Sponsored ADR (BLRX) to a Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2524121960","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524121960?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 04:25","pubTimestamp":1743539123,"startTime":"0","endTime":"0","summary":"Bioline RX Ltd Sponsored ADR (BLRX – Research Report) received a Hold rating and price target from JonesTrading analyst Justin Walsh today. The com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jonestrading-downgrades-bioline-rx-ltd-sponsored-adr-blrx-to-a-hold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jonestrading-downgrades-bioline-rx-ltd-sponsored-adr-blrx-to-a-hold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLRX"],"gpt_icon":0},{"id":"2524927465","title":"BioLine RX Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524927465","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524927465?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 00:38","pubTimestamp":1743439080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 12:38 ET (16:38 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2523835921","title":"BioLine RX Ltd : H.c. Wainwright Adjusts Target Price to $26 From $9 to Reflect 1-for-40 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2523835921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523835921?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 23:29","pubTimestamp":1743434998,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE16S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BLRX"],"gpt_icon":0},{"id":"2523891791","title":"Options Volatility and Implied Earnings Moves Today, March 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523891791","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523891791?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:05","pubTimestamp":1743419105,"startTime":"0","endTime":"0","summary":"Today, several major companies are expected to report earnings: Bioline RX Ltd Sponsored ADR (BLRX), Red Cat Holdings (RCAT), Microvast Holdings (M...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-today-march-31-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-today-march-31-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLRX","BK4157","RCAT","BK4139","BK4603"],"gpt_icon":0},{"id":"2523917158","title":"Options Volatility and Implied Earnings Moves This Week, March 31 – April 03, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523917158","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523917158?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:00","pubTimestamp":1743418828,"startTime":"0","endTime":"0","summary":"This week, several major companies will be reporting earnings. Among them are BlackBerry (BB), Bioline RX Ltd Sponsored ADR (BLRX), Nano-X Imaging ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-this-week-march-31-april-03-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-this-week-march-31-april-03-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNOX","BK4196","BK4097","BK4139","BK4609","BK4547","BLRX","BK4082"],"gpt_icon":0},{"id":"2523917611","title":"Press Release: BioLineRx Reports 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2523917611","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523917611?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"- Reports meaningful progress in the evaluation of assets for potential in-licensing and development in the areas of oncology and rare diseases -. - Executed license agreement with Ayrmid Pharma Ltd. for APHEXDA  with $10 million upfront payment, up to $87 million in commercial milestones, and high double-digit royalties on net sales -. - Completed financings raising combined gross proceeds of $19 million and reduced operating expense run rate by 70%, extending the Company's cash runway through H2 2026 -. - Management to host conference call today, March 31 , at 8:30 am EDT -. TEL AVIV, Israel, March 31, 2025 /PRNewswire/ -- BioLineRx Ltd.  , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results for the year ended December 31, 2024, and provided a corporate update.tumors, and across all territories except Asia- Licen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","BK4022","LU2463526074.USD","BK4232","BK4585","LU1481599808.USD","R","BLRX","IP","SCD","BK4139","BK4136","LU1481600234.SGD","BK4588","BK4109","ASH","LU1487256676.USD"],"gpt_icon":0},{"id":"2523915166","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2523915166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523915166?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 18:00","pubTimestamp":1743415200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPRO","BK4167","PVH","RDUS","PRGS","ANGO","AYI","PVLA","RANI","SPIR","UNF","NNOX","LU0054578231.USD","BK4023","DARE","AMC","BHST","NCNO","CAG","BK4141","OMER","CELC","GWH","RH","TTGT","FC","PROK","LNN","BK4584","BK4524","BK4178","BK4200","MSM","WPRT","SGML","BW","BK4086","REKR","SLP","APOG","BLRX","LW","PENG","LNZA","CUK","LOAR","BK4007","SPWH","FTCI"],"gpt_icon":0},{"id":"2522579890","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522579890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522579890?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:39","pubTimestamp":1743165547,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 31 for the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB0XM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNOX","CRDL","PVH","REKR","FEMY","INR","KYTX","UNCY","ANGO","DARE","WKSP","GOVX","NUTX","CELC","LNZA","MDAI","TLSI","WBA","RLMD","ATAI","SKYH","SGML","PENG","PVLA","AFMD","ADCT","FBIO","BRZE","IKT","LULU","BHST","SLRN","BLRX","FTCI","GEVO","GWH","SDST","CLSD","EDAP","INMB","SPWH","BCAB","TSAT","RANI","CALC","BW","NCNO","WGO","FC","PRGS"],"gpt_icon":0},{"id":"2521174636","title":"BioLineRx to Report 2024 Annual Results on March 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521174636","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521174636?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Management to Hold Conference Call at 8:30 a.m. EDT. TEL AVIV, Israel, March 24, 2025 /PRNewswire/ -- BioLineRx Ltd.  , a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its audited financial results for the year ended December 31, 2024 on Monday, March 31, 2025, before the U.S. markets open.The Company will host a conference call at 8:30 a.m. EDT featuring remarks by Philip Serlin, Chief Executive Officer.To access the conference call, please dial +1-888-281-1167 from the U.S. or +972-3-918-0685 internationally. A live webcast and a replay of the call can be accessed through the event pageon the Company's website. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast. A replay of the call will be available approximately two hours after completion of the live conference call. A dial-in replay of the call will be availabl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biolinerx-report-2024-annual-results-110000681.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biolinerx-report-2024-annual-results-110000681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BLRX","BK4139"],"gpt_icon":0},{"id":"2520439968","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520439968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520439968?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 18:00","pubTimestamp":1742464800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Amprius Tech Inc                                4Q      (.11)  4:05 PM. ·Lands' End Inc.                                   4Q       .57   6:45 AM. ·Lennar Corp Class A                              1Q      1.70       AMC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WOR","CBUS","MGNX","MNSO","BCAB","TH","SKYE","CELC","DRI","SOWG","FBRX","KLC","LVTX","ASO","MBRX","CMC","SPRY","OUST","JEF","SBS","BLRX","MLKN","TITN","RLMD","CURV","FLUX","IFRX","JKS","SLS","BRAG","DERM","GDEV","LPTX","MREO","LEN","NKTX","COYA","BRNS","ACRV","CDLR","RUM","PAYX","THRD","NKE","BBNX","ALUR","TELA","PL"],"gpt_icon":1},{"id":"2520014059","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520014059","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520014059?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:12","pubTimestamp":1742382742,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 21 (estima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL8N3Q20U3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2519082968","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2519082968","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519082968?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 19:50","pubTimestamp":1741953020,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 18 (estima","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL8N3PX0YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2517486434","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517486434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517486434?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 19:42","pubTimestamp":1741347740,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 10 (estima","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ0T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2514323608","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514323608","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514323608?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 20:05","pubTimestamp":1740744352,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 4 (estimat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ12A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2514098175","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514098175","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514098175?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 20:02","pubTimestamp":1740484965,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on February 27 (est","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL5N3PG10A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biolinerx.com","stockEarnings":[{"period":"1week","weight":0.0377},{"period":"1month","weight":-0.1433},{"period":"3month","weight":-0.5189},{"period":"6month","weight":-0.859},{"period":"1year","weight":-0.9018},{"period":"ytd","weight":-0.6787}],"compareEarnings":[{"period":"1week","weight":0.0567},{"period":"1month","weight":-0.0446},{"period":"3month","weight":-0.0802},{"period":"6month","weight":-0.0787},{"period":"1year","weight":0.0308},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.068634},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.044107},{"month":3,"riseRate":0.214286,"avgChangeRate":-0.096578},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.04889},{"month":5,"riseRate":0.538462,"avgChangeRate":0.061857},{"month":6,"riseRate":0.384615,"avgChangeRate":-0.023898},{"month":7,"riseRate":0.538462,"avgChangeRate":0.03754},{"month":8,"riseRate":0.357143,"avgChangeRate":-0.055743},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.016762},{"month":10,"riseRate":0.357143,"avgChangeRate":-0.013928},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.057325},{"month":12,"riseRate":0.357143,"avgChangeRate":-0.060525}],"exchange":"NASDAQ","name":"BioLine Rx","nameEN":"BioLine Rx"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.0","shortVersion":"4.33.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioLine Rx(BLRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioLine Rx(BLRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioLine Rx,BLRX,BioLine Rx股票,BioLine Rx股票老虎,BioLine Rx股票老虎国际,BioLine Rx行情,BioLine Rx股票行情,BioLine Rx股价,BioLine Rx股市,BioLine Rx股票价格,BioLine Rx股票交易,BioLine Rx股票购买,BioLine Rx股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioLine Rx(BLRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioLine Rx(BLRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction